01 1Raks Pharma
01 1MILNACIPRAN HYDROCHLORIDE, API
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-07-25
Pay. Date : 2012-12-05
DMF Number : 26624
Submission : 2012-11-19
Status : Active
Type : II
20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is MILNACIPRAN HYDROCHLORIDE, API, with a corresponding US DMF Number 26624.
Remarkably, this DMF maintains an Active status since its submission on November 19, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 25, 2013, and payment made on December 05, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
LOOKING FOR A SUPPLIER?
Market Place
